Clinical trial
Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder
NCT00135772 is registered in ClinicalTrials.gov with National Institute on Drug Abuse (NIDA) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder
- Lead sponsor
- National Institute on Drug Abuse (NIDA)
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2003
- Completion date
- July 31, 2004
- Enrollment
- 100
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
schizophrenia and disorders with psychotic features, tobacco use disorder